US 12109216
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
granted A61KA61K2300/00A61K31/137
Quick answer
US patent 12109216 (Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome) held by ESSENTIALIS, INC. expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ESSENTIALIS, INC.
- Grant date
- Tue Oct 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K2300/00, A61K31/137, A61K31/155, A61K31/549